Resources

Download this application note and discover 3 case studies. Refine formulations or assess local tolerance in human skin before clinical trials.

Top-level science through the eyes of an expert.Mast cells and anaphylaxis: emerging mechanisms & pathwaysDid you miss the live session? You can now watch the full webinar replay on demand where Dr. Soman Abraham explores groundbreaking discoveries in mast cell biology and their role in anaphylaxis. This session uncovers how mast cells interact with dendritic cells, nerves, and inflammasome pathwaysRead more

Prove ADCC Activityin real human skinFor therapies targeting mast cells, demonstrating antibody-dependent cell-mediated cytotoxicity (ADCC) in complex human tissue is essential.Traditional in vitro assays provide limited context, leaving critical aspects of biological impact unclear. HypoSkin® offers a solution Our ex vivo human skin model lets you assess mast cell depletion in situ, offering a powerful, human-relevant platform to confirm theRead more

Genoskin raises $8.7M series Ato support drug development with ethical, human-based modelsFunding to accelerate global expansion and strengthen scientific leadership We are excited to announce that Genoskin, a leader in developing ex vivo human skin platforms for testing drugs and medical devices, has raised $8.7 million (€8M) in Series A funding. The investment will fuel the company’s global expansion, enhanceRead more

Explore how HypoSkin®—a standardized, injectable, and immunocompetent human skin model—provides a translational, animal-free solution for assessing the immunogenicity of therapeutic compounds. From structural stability to real-time immune response profiling, this white paper delivers data-backed insights designed for pharma and biotech teams advancing injectable drug development.

Top-level science through the eyes of an expert.Join us for the next session of Naked Immunology Webinar series, where we explore cutting-edge advancements in drug delivery and therapeutic innovation. In this session we will discuss how the immune system’s reaction to neuromuscular blockers could offer new therapeutic insights. WATCH NOWThis webinar explores new insights into the antibody responses of patientsRead more